The Commercializing Industrial Biotechnology (CIB) conference spotlights best practices, lessons learned, and technology innovations for accelerating commercial production of bio-based products and building the circular bioeconomy. This is the premier conference focused on scale-up and commercialization of new products in the synthetic biology, fermentation, and industrial biotechnology spaces.

You’ll engage with industrial biotech leaders and practitioners as you explore the latest in the field — including developments that are driving a new wave of products. At CIB, you'll hear hard-won lessons from industry veterans — and draw inspiration for your own technology development efforts while learning and networking about new enabling technologies, products, market needs, and companies.

Abstracts now open! Submit yours here: https://www.aiche.org/sbe/conferences/commercializing-industrial-biotechnology/2025

SESSION TOPICS:
Building the Bioeconomy: Partnerships with Investors, Educators & Government
Technology Translation from Academia to Industry
Commodity Chemicals
Navigating the Contract Manufacturing Network
Building Biomanufacturing at Commercial Scale
Emerging Technologies to Accelerate RD&D
Biomanufacturing With Non-Model Systems
Start-up Showcase

Meet the Chairs:
Jason Ryder, Oobli and University of California, Berkeley
Christine Santos, Manus Bio

Organizing Committee:
Kirsten Benjamin, Pivot Bio
Bo Chen, Gen
Brian Davidson, Oak Ridge National Laboratory
Emily Greenhagen, Ginkgo
Olivier Rolland, L’Oréal


Conference organized by the Society for Biological Engineering

About SBE
Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. Learn more about SBE at https://www.aiche.org/sbe